|
COMMERCE BUSINESS DAILY ISSUE OF AUGUST 17,1998 PSA#2160National Institutes of Health, National Institute of Allergy and
Infectious Diseases, Contract Management Branch, Solar Bldg., Room
3C07, 6003 Executive Blvd. MSC 7610, Bethesda, MD 20892-7610 A -- MICROBIOLOGICAL TUBERCULOSIS SCREENING SOL
RFP-NIH-NIAID-DAIDS-99-16 DUE 111398 POC Mr. Ross Kelley, Contract
Specialist, 301-402-2234 The Opportunistic Infections Research Branch,
Therapeutics Research Program, Division of AIDS, National Institute of
Allergy and Infectious Diseases (NIAID), NIH, has a requirement to
develop therapies for the treatment of AIDS and associated
opportunistic infections. The purpose of this RFP is to seek
responsible offers to establish laboratory facilities for
microbiological tuberculosis screening. This contract is to serve as a
central facility for laboratory in vitro testing of novel compounds.
RESTRICTIONS TO COMPETITION This contract will involve the use of
information on compounds, which may be confidential and proprietary.
All offerors except those deemed by the Government to have an actual or
apparent conflict of interest are eligible to compete. Organizations
that are, or subsidiaries to, pharmaceutical or chemical companies
(i.e., an organization which sells drugs and/or chemicals to the
general public for profit) are examples of organizations that are
excluded from competition. Documentationof commercial interests, such
as investors' prospectus or recent audit, must be supplied in an
offeror's business proposal. The Government reserves the right to
exclude any offeror. If there is ANY question about potential conflicts
or APPARENT conflicts, contact the Contracting Officer. An Advance
Understanding will be inserted in the resultant contract stating that
the NIAID shall be notified if the Contractor's conflict of interest
status has changed and that a determination shall be made regarding the
continuation of the contract. It is anticipated that one (1) cost
reimbursement, completion type contract will be awarded for a period of
seven (7) years, beginning approximately August 17, 1999. RFP
NIH-NIAID-DAIDS-99-16 will be available electronically on or about
August 21, 1998, and may be accessed through the NIAID Contract
Management Branch (CMB) Home Page by using the following electronic
address and instructions: NIAID/CMB Home Page (via the WWW): Use
http://www.niaid.nih.gov/contract to access the NIAID/CMB Home Page.
Once at the NIAID/CMB Home Page, click on the "RFPs" link and then
click on "RFP NIH-NIAID-DAIDS-99-16." Please note that the RFP for this
acquisition has been revised to include only the Work Statement,
Deliverable and Reporting Requirements, Special Requirements and
Mandatory Qualification, if any, the Technical Evaluation Criteria, and
the Specific RFP Instructions and Provisions. All information required
for the submission of an offer will be contained in the electronic RFP
package. Following proposal submission and the initial review process,
offerors comprising the competitive range will be requested to provide
additional documentation to the Contracting Officer. Responses to this
RFP will be due on November 13, 1998. Any responsible offeror may
submit a proposal which will be considered by the Government. This
advertisement does not commit the Government to award a contract. Point
of Contact: Ross Kelley, Contract Specialist Electronic mail address:
rk17@nih.gov Telephone: (301) 402-2234 FAX: (301) 402-0972 No collect
calls will be accepted. Posted 08/13/98 (W-SN236908). (0225) Loren Data Corp. http://www.ld.com (SYN# 0004 19980817\A-0004.SOL)
A - Research and Development Index Page
|
|